AIM ImmunoTech Inc (AIM)

AIM ImmunoTech (AIM) Financial Statements


AIM ImmunoTech Financial Overview

AIM ImmunoTech's market cap is currently ―. The company's EPS TTM is $-0.4; its P/E ratio is -1.16; AIM ImmunoTech is scheduled to report earnings on August 15, 2023, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 49.00K$ 57.00K$ 21.00K$ 30.00K$ 33.00K
Gross Profit$ 49.00K$ 203.00K$ 21.00K$ -39.00K$ -44.00K
EBIT$ 4.77M$ -5.00M$ -6.38M$ -4.85M$ -3.82M
EBITDA$ 4.82M$ -4.83M$ -6.36M$ -4.82M$ -3.79M
Net Income Common Stockholders$ 5.03M$ -4.39M$ -6.38M$ -4.85M$ -3.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 30.85M$ 34.19M$ 36.74M$ 41.77M$ 44.54M
Total Assets$ 37.31M$ 40.49M$ 46.28M$ 50.88M$ 54.16M
Total Debt$ 814.00K$ 837.00K$ 866.00K$ 889.00K$ 144.00K
Net Debt$ -30.04M$ -33.35M$ -35.88M$ -40.88M$ -44.40M
Total Liabilities$ 2.47M$ 2.02M$ 3.59M$ 2.10M$ 854.00K
Stockholders Equity$ 34.99M$ 38.47M$ 42.70M$ 48.78M$ 53.30M
Cash Flow-
Free Cash Flow$ -3.63M$ -2.64M$ -4.99M$ -2.36M$ -2.79M
Operating Cash Flow$ -3.66M$ -6.07M$ -4.97M$ -2.31M$ -2.76M
Investing Cash Flow$ -78.00K$ 3.36M$ 250.00K$ 7.72M$ -346.00K
Financing Cash Flow$ 100.00K-$ 25.00K$ 55.00K$ 0.00
Currency in USD

AIM ImmunoTech Earnings and Revenue History

AIM ImmunoTech Debt to Assets

AIM ImmunoTech Cash Flow

AIM ImmunoTech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis